Annovis Bio Inc (NYSE:ANVS) shares, rose in value on Friday, June 20, with the stock price down by -3.70% to the previous day’s close as strong demand from buyers drove the stock to $2.60.
Actively observing the price movement in the last trading, the stock closed the session at $2.70. Referring to stock’s 52-week performance, its high was $17.88, and the low was $1.11. On the whole, ANVS has fluctuated by 21.50% over the past month.
With the market capitalization of Annovis Bio Inc currently standing at about $50.66 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-13.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ANVS’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of ANVS currently trading nearly -2.40% and 30.38% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 53.09, while the 7-day volatility ratio is showing 4.48% which for the 30-day chart, stands at 7.87%. Furthermore, Annovis Bio Inc (ANVS)’s beta value is 1.62, and its average true range (ATR) is 0.27.
A comparison of Annovis Bio Inc (ANVS) with its peers suggests the former has fared considerably weaker in the market. ANVS showed an intraday change of -3.70% in last session, and over the past year, it shrunk by -52.81%%.
Data on historical trading for Annovis Bio Inc (NYSE:ANVS) indicates that the trading volumes over the past 3 months, they’ve averaged 440.77K. According to company’s latest data on outstanding shares, there are 19.49 million shares outstanding.
Nearly 14.56% of Annovis Bio Inc’s shares belong to company insiders and institutional investors own 15.84% of the company’s shares. The stock has fallen by -48.31% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ANVS stock heading into the next quarter.
